Volume 17, Issue 2, Pages (February 2009)

Slides:

Advertisements

Similar presentations

Volume 14, Issue 2, Pages (May 2008)

Advertisements

Central Venous Catheter Malposition Presenting as Chest Pain

Volume 15, Issue 5, Pages (May 2013)

Molecular Therapy - Methods & Clinical Development

Volume 20, Issue 2, (February 2012)

Hepatic AAV Gene Transfer and the Immune System: Friends or Foes?

Liver Transplantation: From Inception to Clinical Practice

Genome-editing Technologies for Gene and Cell Therapy

Molecular Therapy - Methods & Clinical Development

Volume 16, Issue 8, Pages (August 2008)

162. Stability of Polymer/Plasmid DNA Complexes In Vitro and In Vivo

Congestive hepatopathy after Fontan operation and related factors assessed by transient elastography Byung Won Yoo, MD, Jae Young Choi, MD, PhD, Lucy.

Direct Conversion of Skin Cells into Blood: Alchemy or Science?

Molecular Therapy Volume 20, Pages S261-S262 (May 2012) DOI: /S (16)

Volume 19, Issue 4, Pages (April 2011)

Liver Failure Secondary to Amyloid Light-Chain Amyloidosis

Molecular Therapy - Nucleic Acids

637. Effect of PEG Grafting Degree on Morphology and Transfection Efficiency of Polycation-g-PEG/DNA Nanoparticles Molecular Therapy Volume 20, (May.

Pre-existing Immunity and Passive Immunity to Adenovirus 5 Prevents Toxicity Caused by an Oncolytic Adenovirus Vector in the Syrian Hamster Model Debanjan.

EUS-guided coiling of hepatic artery pseudoaneurysm in 2 stages

Volume 26, Issue 2, Pages (February 2018)

Preclinical toxicology of oncolytic adenovirus-mediated cytotoxic and interleukin-12 gene therapy for prostate cancer Svend O Freytag, Yingshu Zhang,

Efficacy and Safety of Pancreas-Targeted Hydrodynamic Gene Delivery in Rats Kohei Ogawa, Kenya Kamimura, Yuji Kobayashi, Hiroyuki Abe, Takeshi Yokoo,

Intraluminal Shunt for the Thoracic Aorta: Blood Flow and Function in Chronic Studies Steven J Van Voorst, MD, Gregory S Labranche, DVM, Samir Rustom,

Volume 16, Issue 2, Pages (February 2008)

Clinical trials of intracoronary bone marrow cell transfer after myocardial infarction: The Hannover experience Helmut Drexler Biology of Blood and.

Volume 19, Issue 3, Pages (March 2011)

Fatal Tumor Thrombosis Due to an Inferior Vena Cava Leiomyosarcoma in a Patient With Antiphospholipid Antibody Syndrome Joseph D. Espiritu, MD, Michael.

Volume 20, Issue 10, Pages (October 2012)

Volume 16, Issue 8, Pages (August 2008)

Volume 18, Issue 11, Pages (November 2010)

Genome-editing Technologies for Gene and Cell Therapy

Valder R Arruda, Patricia Favaro, Jonathan D Finn Molecular Therapy

Volume 21, Issue 4, Pages (April 2013)

Volume 21, Issue 2, Pages (February 2013)

Volume 20, Issue 12, Pages (December 2012)

Kenya Kamimura, Guisheng Zhang, Dexi Liu Molecular Therapy

Molecular Therapy Volume 7, Issue 5, (May 2003) DOI: /S (16)

Volume 12, Issue 6, Pages (December 2005)

Volume 18, Issue 1, Pages (January 2010)

847. Eradication of Therapy-Resistant Human Prostate Tumors Using an Ultrasound Guided Site-Specific Cancer Terminator Virus Delivery Approach Molecular.

Designer Lipids Advance Systemic siRNA Delivery

Volume 18, Issue 1, Pages (January 2010)

Volume 24, Issue 10, Pages (October 2016)

Volume 16, Issue 6, Pages (June 2008)

Volume 2, Issue 11, Pages (November 2017)

Computer-assisted Hydrodynamic Gene Delivery

Volume 16, Issue 12, Pages (December 2008)

Cyclophosphamide-Induced Hepatitis in Wegener's Granulomatosis

Molecular Therapy Volume 18, Pages S260-S261 (May 2010) DOI: /S (16)

Novel use of percutaneous thrombosuction to rescue the early thrombosis of the conduit vein graft after living donor liver transplantation Kuo-Shyang.

Elizabeth M Hadac, Elizabeth J Kelly, Stephen J Russell

In This Issue Molecular Therapy Volume 16, Issue 4, (April 2008)

Volume 23, Issue 12, Pages (December 2015)

Volume 86, Issue 4, (October 2014)

Mark J. Koury, MD, John H. Newman, MD, John J. Murray, MD

Volume 19, Issue 7, Pages (July 2011)

Molecular Therapy Volume 21, Pages S247-S248 (May 2013)

86. A Highly Compact Epitope-Based Marker Suicide Gene for Safer and Easier Adoptive T-Cell Gene Therapy Molecular Therapy Volume 20, Pages S35-S36.

Richard L. McCann, M.D., Raymond Makhoul, M.D., Ralph Damiano, M.D.

Molecular Therapy - Nucleic Acids

Volume 139, Issue 5, Pages (November 2010)

Volume 16, Issue 4, Pages (April 2008)

Molecular Therapy - Methods & Clinical Development

Enteral stents: from esophagus to colon

LINDA S. SNYDER, M.D., RUSSELL I. HEIGH, M.D., MONTE L. ANDERSON, M.D.

Efficacy of Helper-dependent Adenovirus Vector-mediated Gene Therapy in Murine Glycogen Storage Disease Type Ia Dwight D Koeberl, B Sun, A Bird, YT Chen,

Volume 16, Issue 4, Pages (April 2008)

Molecular Therapy - Methods & Clinical Development

Use of an endovascular occlusion balloon for control of unremitting venous hemorrhage Bryan W. Tillman, MD, PhD, Patrick S. Vaccaro, MD, Jean E. Starr,

Presentation transcript:

Volume 17, Issue 2, Pages 327-333 (February 2009) Efficient, Long-term Hepatic Gene Transfer Using Clinically Relevant HDAd Doses by Balloon Occlusion Catheter Delivery in Nonhuman Primates Nicola Brunetti-Pierri, Gary E Stapleton, Mark Law, John Breinholt, Donna J Palmer, Yu Zuo, Nathan C Grove, Milton J Finegold, Karen Rice, Arthur L Beaudet, Charles E Mullins, Philip Ng Molecular Therapy Volume 17, Issue 2, Pages 327-333 (February 2009) DOI: 10.1038/mt.2008.257 Copyright © 2009 The American Society of Gene Therapy Terms and Conditions

Figure 1 A sausage-shaped balloon catheter is positioned in the inferior vena cava (IVC) under fluoroscopic guidance. Inflation of the balloon with contrast medium results in hepatic venous outflow occlusion from the hepatic veins (HVs). The HDAd is administered by injection through a percutaneously positioned hepatic artery (HA) catheter. Fluoroscopic image of balloon inflation with contrast medium from baboon 16855 is shown on the left. Fluoroscopic image of injection of contrast medium into the HA from baboon 11891 is shown on the right. Molecular Therapy 2009 17, 327-333DOI: (10.1038/mt.2008.257) Copyright © 2009 The American Society of Gene Therapy Terms and Conditions

Figure 2 Transgene levels and toxicity measurements for baboons injected with 1 × 1011 viral particles (vp)/kg. (a) Serum baboon α-fetoprotein (bAFP) levels, (b) alanine aminotransferase (ALT), (c) aspartate aminotransferase (AST), and (d) interleukin-6 (IL-6) levels in baboons injected 1 × 1011 vp/kg of HDΔ21.7E4PEPCK-bAFP-WL or saline. Numbers in parenthesis represent the normal range, if known. Molecular Therapy 2009 17, 327-333DOI: (10.1038/mt.2008.257) Copyright © 2009 The American Society of Gene Therapy Terms and Conditions

Figure 3 Transgene levels and toxicity measurements for baboons injected with 3 × 1010 and 1 × 1010 viral particles (vp)/kg. (a) Serum baboon α-fetoprotein (bAFP) levels, (b) alanine aminotransferase (ALT), (c) aspartate aminotransferase (AST), and (d) interleukin-6 (IL-6) levels in baboons injected 3 × 1010 or 1 × 1010 vp/kg of HDΔ21.7E4PEPCK-bAFP-WL. Numbers in parenthesis represent the normal range, if known. Molecular Therapy 2009 17, 327-333DOI: (10.1038/mt.2008.257) Copyright © 2009 The American Society of Gene Therapy Terms and Conditions

Figure 4 Histopathology of baboon livers. Hematoxylin and eosin histology of liver from baboon 16290 at (a) day 8 and (b) day 28, baboon 16728 at (c) day 7 and (d) day 28, (e) baboon 16105 at day 28 and (f) baboon 16966 at day 28 showing rare and minor abnormalities. Molecular Therapy 2009 17, 327-333DOI: (10.1038/mt.2008.257) Copyright © 2009 The American Society of Gene Therapy Terms and Conditions